Michael Higgins

Stock Analyst at Ladenburg Thalmann

(0.64)
# 3,734
Out of 4,711 analysts
24
Total ratings
30%
Success rate
-10.46%
Average return

Stocks Rated by Michael Higgins

Marinus Pharmaceuticals
Aug 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.23
Upside: -
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $19.03
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $19.34
Upside: +255.48%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.00
Upside: +600.63%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,400.15%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $0.95
Upside: +6,231.79%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $56.12
Upside: -37.63%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2$50
Current: $0.97
Upside: +5,065.82%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130$80
Current: $0.62
Upside: +12,803.23%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.70
Upside: +1,106.90%
Upgrades: Buy
Price Target: $29
Current: $35.41
Upside: -18.10%
Reinstates: Buy
Price Target: n/a
Current: $3.23
Upside: -